本信息仅供教育用途，不构成医疗建议。请务必咨询合格的医疗专业人员。
说明, 用法用量, 不良反应, 禁忌. Data from EMA, URPL, openFDA and other regulatory sources.
| Salbutamol | Salmeterol | |
|---|---|---|
| 活性成分 | Salbutamolum | Salmeterolum + Fluticasoni propionas |
| ATC 代码 | R03CC02 | R03AK06 |
| 剂型 | Tabletki | Proszek do inhalacji, podzielony |
| 用法用量 | 4 mg | (50 mikrogramów + 250 mikrogramów)/dawkę |
| 给药途径 | doustna | wziewna |
| 生产厂家 | Zakłady Farmaceutyczne POLPHARMA S.A. | InPharm Sp. z o.o. |
Salbutamol (INN: Salbutamolum, ATC R03CC02) and Salmeterol (INN: Salmeterolum + Fluticasoni propionas, ATC R03AK06) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
本信息仅供教育用途，不构成医疗建议。请务必咨询合格的医疗专业人员。